Inovalon to Participate at Annual Morgan Stanley and Bank of America Merrill Lynch Healthcare Conferences

BOWIE, Md., Sept. 06, 2017 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that Keith Dunleavy, M.D., Inovalon’s chief executive officer and chairman of the board, and Christopher Greiner, Inovalon’s chief financial officer and chief operating officer, will present at the upcoming Morgan Stanley 2017 Global Healthcare Unplugged Conference on September 11- 12, 2017, at the Grand Hyatt Hotel in New York City.

The presentation will take place at 4:15 p.m. (ET) on Monday, September 11, 2017. Investors may access a live audio webcast of the presentation on the Investor Relations section of Inovalon’s website at www.inovalon.com. An archived version will remain posted for a limited time.

Additionally, Inovalon will be participating at the Bank of America Merrill Lynch 2017 Healthcare Supply Channel and HCIT Conference in Boston on September 26, 2017.

About Inovalon

Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Through the Inovalon ONE™ Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem on massive scale, aggregate and analyze data in petabyte volumes to arrive at sophisticated insights in real-time, drive impact wherever it is analytically identified best to intervene, and intuitively visualize data and information to inform business strategy and execution. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action^®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 858,000 physicians, 377,000 clinical facilities, and more than 230 million Americans. For more information, visit www.inovalon.com.

Contacts:
Kim Collins
Phone: 301-809-4000 x1473                                 
[email protected]

George Price (Investors)
Phone: 301-809-4000 x1190
[email protected]